Even so, taking the PREPL expression, its cellular localization pattern, and the strong parallel with POP, concerning the interaction with α-Syn, the results described in the present work put PREPL as another target for drugs aiming to treat synucleinopathies (e.g., Parkinson’s disease). The gene discussed is PREPL; the disease is synucleinopathy.